Key result
Plug-based vascular closure devices were associated with a higher rate of access-related vascular complications compared to suture-based devices after transfemoral TAVI.
Why the study?
Vascular access site complications increase morbidity and mortality after TAVI, but current results comparing plug-based and suture-based vascular closure devices remain inconsistent.
Does a plug-based vascular closure device reduce access-related vascular complications compared to a suture-based device in patients undergoing transfemoral TAVI?
Cohort (n=10,120)
Yes
Does a plug-based vascular closure device reduce access-related vascular complications compared to a suture-based device in patients undergoing transfemoral TAVI?
Plug-based vascular closure devices are associated with a higher rate of access-related vascular complications, particularly minor complications requiring endovascular treatment, compared to suture-based devices after transfemoral TAVI.
Answers are grounded in this paper and cite their sources.
P-VCD associated with more large-bore access complications than S-VCD after TAVI; leaves open need for randomized confirmation.
BACKGROUND: Vascular access site complications are associated with increased morbidity and mortality after transcatheter aortic valve implantation (TAVI). Current results comparing strategies with plug- (P-VCD; MANTA) and suture-based vascular closure devices (S-VCD; Perclose ProGlide) remain inconsistent. AIMS: It was our aim to assess the incidence of access-related vascular complications after P-VCD or S-VCD strategies after transfemoral TAVI. METHODS: The Plug or sUture based vascuLar cloSurE after TAVI (PULSE) registry retrospectively evaluated 10,120 consecutive patients who had undergone transfemoral TAVI at 10 centres from 2016 to 2021. A propensity score was used to match 900 P-VCD patients with 1,800 S-VCD patients in a 1:2 fashion. The primary outcome measures were major and minor access-related vascular complications at the primary access site, adjudicated according to Valve Academic Research Consortium 3 definitions. RESULTS: The median age was 81.8 years, 46.4% of patients were female, and the median European System for Cardiac Operative Risk Evaluation II was 3.50%. In matched P-VCD and S-VCD groups, large-bore access-related complications occurred in 14.9% vs 10.3% (p<0.001; major: 3.6% vs 4.6%; p=0.218; minor: 11.3% vs 5.8%; p<0.001) of patients. Bleeding accounted for most of these complications (9.6% vs 7.2%; p=0.028) and was treated with endovascular balloon inflation (5.4% vs 2.6%; p<0.001), stent implantation (4.7% vs 0.7%; p<0.001) or surgical repair (0.7% vs 1.7%; p=0.03). CONCLUSIONS: P-VCD were associated with higher rates of primary access-related vascular complications, driven by minor complications, compared to S-VCD. Endovascular treatment was more common after P-VCD failure.
No takes yet. Share an insight, caveat, or question.
Grundmann et al. (2025) conducted a cohort in transfemoral TAVI (n=10,120). Plug-based vascular closure device (P-VCD) vs. Suture-based vascular closure device (S-VCD) was evaluated on major and minor access-related vascular complications at the primary access site (p=<0.001). Plug-based vascular closure devices were associated with a higher rate of access-related vascular complications compared to suture-based devices after transfemoral TAVI.
Synapse has enriched 10 related papers. Consider them for comparative context: